A phase I study of JS001, a humanized PD-1mAbin patients with advanced triple negative breast cancer.

e15093Background: Triple negative breast cancer (TNBC), as defined by ER, PR and HER2 negative expression in tumor,has limited treatment options beyond traditional chemotherapy.Immunotherapy is a n...